Vstrip Antigen Rapid Test Kit

CLINICAL PERFORMANCE
The performance of the Vstrip COVID-19 Antigen Rapid Test for detection of SARS-CoV-2 was established with 148 individual symptomatic patients who were suspected of COVID-19

• Sensitivity: 90.6%  (PPA) (95%CI: 74.98% – 98.02%)
• Specificity: 99.1%  (NPA) (95%CI: 95.29% – 99.98%)
• Accuracy: 97.3%    (95%CI: 93.22% – 99.26%)

ANALYTICAL SENSITIVITY
Inactivated SARS-CoV-2 (USA-WA1/2020), gamma-Irradiated: 3.13×10² TICD₅₀/ml

ANALYTICAL SPECIFICITY
The cross reactivity study was evaluated with a total of 12 bacteria strains and 15 viruses strains. None of these tested microorganisms gave a positive result

CERTIFICATION
ISO 13485:2016
TFDA_Case-Specific Approval of Disease Control for Manufacture No.1096813815
INDIA CDSCO Licence to Import Medical Device IMP/IVD/2021/000128
CE-IVD
SINGAPORE HSA Provisional Authorization
Philippines FDA Special Certification